There is a growing need in cell-based assays for drug discovery and disease modeling to closely represent biologically relevant microenvironments. This has led to increased interest in three-dimensional (3D) models for assay development and phenotypic screening as they better represent the complexity of human tissue. However, reliability and scalability challenges associated with 3D model development impacts its widespread adoption.
In this webinar, experts discuss how to address these challenges to gain crucial insights about compound efficacy, biological complexity, and physiological relevance of 3D assay results. Key takeaways include: